These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23649394)

  • 1. [Structural biology for developing antimalarial compounds].
    Tanaka N; Umeda T; Kusakabe Y; Nakanishi M; Kitade Y; Nakamura KT
    Yakugaku Zasshi; 2013; 133(5):527-37. PubMed ID: 23649394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of S-adenosyl-L-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum.
    Tanaka N; Nakanishi M; Kusakabe Y; Shiraiwa K; Yabe S; Ito Y; Kitade Y; Nakamura KT
    J Mol Biol; 2004 Oct; 343(4):1007-17. PubMed ID: 15476817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum.
    Umeda T; Tanaka N; Kusakabe Y; Nakanishi M; Kitade Y; Nakamura KT
    Sci Rep; 2011; 1():9. PubMed ID: 22355528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor.
    Cobb RE; Bae B; Li Z; DeSieno MA; Nair SK; Zhao H
    Chem Commun (Camb); 2015 Feb; 51(13):2526-8. PubMed ID: 25567100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
    Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
    Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.
    Konzuch S; Umeda T; Held J; Hähn S; Brücher K; Lienau C; Behrendt CT; Gräwert T; Bacher A; Illarionov B; Fischer M; Mordmüller B; Tanaka N; Kurz T
    J Med Chem; 2014 Nov; 57(21):8827-38. PubMed ID: 25254502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, evolution, and inhibitor interaction of S-adenosyl-L-homocysteine hydrolase from Plasmodium falciparum.
    Bujnicki JM; Prigge ST; Caridha D; Chiang PK
    Proteins; 2003 Sep; 52(4):624-32. PubMed ID: 12910461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2-modified aristeromycins and their analogs as potent inhibitors against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase.
    Ando T; Iwata M; Zulfiqar F; Miyamoto T; Nakanishi M; Kitade Y
    Bioorg Med Chem; 2008 Apr; 16(7):3809-15. PubMed ID: 18295495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [S-adenosyl-L-homocysteine hydrolase as an attractive target for antimicrobial drugs].
    Nakanishi M
    Yakugaku Zasshi; 2007 Jun; 127(6):977-82. PubMed ID: 17541248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting an Aromatic Hotspot in Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase with β-Arylpropyl Analogues of Fosmidomycin.
    Sooriyaarachchi S; Chofor R; Risseeuw MD; Bergfors T; Pouyez J; Dowd CS; Maes L; Wouters J; Jones TA; Van Calenbergh S; Mowbray SL
    ChemMedChem; 2016 Sep; 11(18):2024-36. PubMed ID: 27487410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Fosmidomycin analogues with altered chelating moieties do not inhibit 1-deoxy-d-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum growth in vitro.
    Chofor R; Risseeuw MD; Pouyez J; Johny C; Wouters J; Dowd CS; Couch RD; Van Calenbergh S
    Molecules; 2014 Feb; 19(2):2571-87. PubMed ID: 24566322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
    Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
    J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
    Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
    Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
    Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
    Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of S-adenosyl-L-homocysteine hydrolase from Plasmodium falciparum.
    Tanaka N; Nakanishi M; Kusakabe Y; Shiraiwa K; Yabe S; Ito Y; Kitade Y; Nakamura KT
    Nucleic Acids Symp Ser (Oxf); 2004; (48):281-2. PubMed ID: 17150588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
    J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.